Abcuro Competitors and Similar CompaniesClear all
Abcuro's competitors and similar companies include Paragon Gene Therapy and Neogene Therapeutics.
 Paragon Gene Therapy Paragon Gene Therapy is a company that focuses on transformative technologies, including gene therapies, vaccines, and oncology immunotherapies. |  Neogene Therapeutics Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer. | ||
Founding Date | Founding Date 2015 | Founding Date 1990 | Founding Date 2018 |
Type | Type Private | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Newton, US HQ | Locations Baltimore, US HQ | Locations New York, US HQ Amsterdam, NL |
Employees | Employees 514% increase | Employees 59 | Employees 191 |
Funding | |||
Latest funding round | Latest funding round $ 8m (over 7 years ago) | Latest funding round N/A | Latest funding round $ 110m (almost 6 years ago) |
Total funding raised | Total funding raised $ 10.3m | Total funding raised $ 20m | Total funding raised $ 110m |
For sources of this data, please see the company profile
View Company Profiles
Paragon Gene Therapy
HQ
Baltimore, US
Paragon Gene Therapy is a company that focuses on transformative technologies, including gene therapies, vaccines, and oncology immunotherapies.
View companyNeogene Therapeutics
HQ
New York, US
Employees
191
Neogene Therapeutics is a pre-clinical stage biotechnology company that develops a new class of personalized T cell therapies to treat cancer.
View company